FIDJI-VERTEBRAL BODY REPLACEMENT TYPE 1, 2, 3 AND 4

K042714 · Spine Next America Corporation · MQP · Dec 29, 2004 · Orthopedic

Device Facts

• Record ID: K042714
• Device Name: FIDJI-VERTEBRAL BODY REPLACEMENT TYPE 1, 2, 3 AND 4
• Applicant: Spine Next America Corporation
• Product Code: MQP · Orthopedic
• Decision Date: Dec 29, 2004
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3060
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

FIDJI types 1, 2, 3, and 4 are vertebral body replacement devices that are intended for use in the thoracic and/or thoracolumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body resected or excised (i.e., partial or total vertebrectomy procedures) due to tumor or trauma (i.e., fracture). The device is designed to restore the biomechanical integrity of the anterior, middle, and posterior spinal column even in the absence of fusion for a prolonged period. These devices are intended to be used with bone graft and supplemental fixation, such as the Spinal Concepts, Inc. InCompass System.

Device Story

FIDJI Types 1, 2, 3, and 4 are hollow, tapered vertebral body replacement blocks; machined from PEEK OPTIMA (polyetheretherketone); feature angled teeth on cephalad and caudal surfaces for stability; include tantalum inserts for radiographic visualization. Used in thoracic/thoracolumbar spine (T1-L5) to replace collapsed, damaged, or unstable vertebral bodies following vertebrectomy. Implanted by surgeons; requires supplemental fixation (e.g., InCompass System) and bone graft. Restores biomechanical integrity of spinal column. Mechanical testing confirms functional support under physiologic loads.

Clinical Evidence

Bench testing only. Mechanical testing demonstrated that the devices exhibit the functional requirements to support their use as vertebral body replacements under normal physiologic loads in the spine.

Technological Characteristics

Materials: PEEK OPTIMA (ASTM F2026). Features: Hollow, tapered blocks with angled teeth on cephalad/caudal surfaces; tantalum inserts for radiographic marking. Energy source: None (mechanical implant). Connectivity: None. Sterilization: Not specified.

Indications for Use

Indicated for patients requiring vertebral body replacement in the thoracic or thoracolumbar spine (T1-L5) following partial or total vertebrectomy due to tumor or trauma (fracture).

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

• Synthes Vertebral Spacer (K011037)
• EBI CAS Spine Spacer (K042268)
• Medtronic Sofamor Danek Vertestack (K031780)

Submission Summary (Full Text)

{0}------------------------------------------------

## 510(K) Summary

| Submitted By: | Lisa Peterson<br>Regulatory Affairs Manager<br>Spinal Concepts, Inc.<br>5301 Riata Park Court, Bldg. F<br>Austin, TX 78727<br>512-918-2700<br>December 8, 2004 |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Trade Name: | Spinal Concepts Inc. FIDJI® Types 1,2,3, and |
| Classification Name: | Vertebral Body Replacement |
| Product Code: | MOP |

Predicate Device: FIDJI types 1,2,3, and 4 are substantially equivalent to the Synthes Vertebral Spacer (K011037), EBI CAS Spine Spacer (K042268), and Medtronic Sofamor Danek Vertestack (K031780).

Device Description: The FIDJI Vertebral Body Replacement Types 1, 2, 3, and 4 devices are hollow blocks that are machined from PEEK OPTIMA® (polyetheretherketone, ASTM F2026); the blocks are tapered to aid in maintaining lordosis of the spine following implantation. The devices have angled teeth on the cephalad and caudal surfaces. The devices include tantalum inserts that serve as a location and orientation markers for radiographs.

Intended Use: FIDJI types 1,2,3, and 4 are vertebral body replacement devices that are intended for use in the thoracic and/or thoracolumbar spine (T1 - L5) to replace a collapsed, damaged or unstable vertebral body resected or excised (i.e., partial or total vertebrectomy procedures) due to tumor or trauma (i.e., fracture). These devices are designed to restore the biomechanical integrity of the anterior, middle and posterior spinal column even in the absence of fusion for a prolonged period. These devices are intended to be used with bone graft and supplemental fixation, such as the Spinal Concepts, Inc. InCompass System.

Mechanical Testing: Mechanical testing demonstrated that FIDJI types 1,2,3, and 4 exhibit the functional requirements to support their use as vertebral body replacements under normal physiologic loads in the spine.

Page 1 of 1

{1}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a bird in flight, composed of three curved lines.

Public Health Service

DEC 2 9 2004

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Ms. Lisa Peterson Regulatory Affairs Manager Spinal Concepts, Inc. 5301 Riata Park Court, Building. F Austin, Texas 78727

Re: K042714

Trade/Device Name: FIDJI Vertebral Body Replacement Types 1, 2, 3, and 4 Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: II Product Code: MQP Dated: December 3, 2004 Received: December 6, 2004

Dear Ms. Peterson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{2}------------------------------------------------

Page 2 - Mr. Justin Eggleton

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Mark A. Milken

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

## Ko42714

## INDICATIONS FOR USE STATEMENT

510(k) Number (if known): K042714

Device Name:

Spinal Concepts, Inc. FIDJI Vertebral Body Replacement Types 1, 2, 3, and 4

Indications for Use:

FIDJI types 1, 2, 3, and 4 are vertebral body replacement devices that are intended for use in the thoracic and/or thoracolumbar spine (T1-L5) to replace a collapsed, damaged or unstable vertebral body resected or excised (i.e., partial or total vertebrectomy procedures) due to tumor or trauma (i.e., fracture). The device is designed to restore the biomechanical integrity of the anterior, middle, and posterior spinal column even in the absence of fusion for a prolonged period. These devices are intended to be used with bone graft and supplemental fixation, such as the Spinal Concepts, Inc. InCompass System.

Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH. Office of Device Evaluation (ODE)

Mark A. Millerson

Division of General, Restorative, and Neurological Devices

**510(k) Number** K042714